Oklahoma Code § 36-6060.11

Title 36. Insurance: Benefits required
Open in Lexace · Ask the AI about this section
A.  Subject to the limitations set forth in this section and
Sections 6060.12 and 6060.13 of this title, any health benefit plan
that is offered, issued, or renewed in this state on or after
January 1, 2000, shall provide benefits for treatment of mental
health and substance use disorders.
B.  1.  Benefits for mental health and substance use disorders
shall be equal to benefits for treatment of and shall be subject to
the same preauthorization and utilization review mechanisms and
other terms and conditions as all other physical diseases and
disorders including, but not limited to:
a. coverage of inpatient hospital services for either
twenty-six (26) days or the limit for other covered
illnesses, whichever is greater,
b. coverage of outpatient services,
c. coverage of medication,
d. maximum lifetime benefits,
e. copayments,
f. coverage of home health visits,
g. individual and family deductibles, and
h. coinsurance.
2.  Treatment limitations applicable to mental health or
substance use disorder benefits shall be no more restrictive than
the predominant treatment limitations applied to substantially all
medical and surgical benefits covered by the plan.  There shall be
no separate treatment limitations that are applicable only with
respect to mental health or substance abuse disorder benefits.
C.  A health benefit plan shall not impose a nonquantitative
treatment limitation with respect to mental health and substance use
disorders in any classification of benefits unless, under the terms
of the health benefit plan as written and in operation, any
processes, strategies, evidentiary standards or other factors used
in applying the nonquantitative treatment limitation to mental
health disorders in the classification are comparable to and applied

no more stringently than to medical and surgical benefits in the
same classification.
D.  All health benefit plans must meet the requirements of the
federal Paul Wellstone and Pete Domenici Mental Health Parity and
Addiction Equity Act of 2008, as amended, and federal guidance or
regulations issued under these acts including 45 CFR 146.136, 45 CFR
147.160, 45 CFR 156.115(a)(3), 42 U.S.C. 300gg-26(a), 29 U.S.C.
1185a(a), and 26 U.S.C. 9812.
E.  Beginning on or after January 1, 2000, each insurer that
offers, issues or renews any individual or group health benefit plan
providing mental health or substance use disorder benefits shall
submit an annual report to the Insurance Commissioner on or before
April 1 of each year that contains the following:
1.  A description of the process used to develop or select the
medical necessity criteria for mental health and substance use
disorder benefits and the process used to develop or select the
medical necessity criteria for medical and surgical benefits;
2.  Identification of all nonquantitative treatment limitations
applied to both mental health and substance use disorder benefits
and medical and surgical benefits within each classification of
benefits; and
3.  The results of an analysis that demonstrates that for the
medical necessity criteria described in paragraph 1 of this
subsection and for each nonquantitative treatment limitation
identified in paragraph 2 of this subsection, as written and in
operation, the processes, strategies, evidentiary standards or other
factors used in applying the medical necessity criteria and each
nonquantitative treatment limitation to mental health and substance
use disorder benefits within each classification of benefits are
comparable to and are applied no more stringently than to medical
and surgical benefits in the same classification of benefits.  At a
minimum, the results of the analysis shall:
a. identify and clearly define the factors and terms used
to determine that a nonquantitative treatment
limitation will apply to a benefit,
b. identify and clearly define the specific evidentiary
standards used to define the factors and any other
evidence relied upon in designing each nonquantitative
treatment limitation,
c. provide the detailed, written, and reasoned
comparative analyses including the results of the
analyses performed to determine that the processes and
strategies used to design each nonquantitative
treatment limitation, as written, and the as written
processes and strategies used to apply the
nonquantitative treatment limitation to mental health
and substance use disorder benefits are comparable to

and applied no more stringently than the processes and
strategies used to design each nonquantitative
treatment limitation, as written, and the as written
processes and strategies used to apply the
nonquantitative treatment limitation to medical and
surgical benefits,
d. provide the detailed, written, and reasoned
comparative analyses including the results of the
analyses performed to determine that the processes and
strategies used to apply each nonquantitative
treatment limitation, in operation, for mental health
and substance use disorder benefits are comparable to
and applied no more stringently than the processes or
strategies used to apply each nonquantitative
treatment limitation for medical and surgical benefits
in the same classification of benefits, and
e. disclose the specific findings and conclusions reached
by the insurer that the results of the analyses
required by this subsection indicate whether the
insurer is in compliance with this section and the
Paul Wellstone and Pete Domenici Mental Health Parity
and Addiction Equity Act of 2008, as amended, and its
implementing and related regulations including 45 CFR
146.136, 45 CFR 147.160, 45 CFR 156.115(a)(3), 42
U.S.C. 300gg-26(a), 29 U.S.C. 1185a(a), and 26 U.S.C.
9812.
F.  The findings and conclusions shall include sufficient detail
to fully explain such findings including methodologies for the
analyses, detailed descriptions of each treatment limitation for
mental health and substance use disorder benefits compared to each
treatment limitation for medical and surgical benefits, and detailed
descriptions of all criteria involved for approving mental health
and substance use disorder benefits as compared to the criteria
involved for approving medical and surgical benefits.
G.  The Commissioner shall implement and enforce any applicable
provisions of the Paul Wellstone and Pete Domenici Mental Health
Parity and Addiction Equity Act of 2008, as amended, and federal
guidance or regulations issued under these acts including 45 CFR
146.136, 45 CFR 147.136, 45 CFR 147.160, 45 CFR 156.115(a)(3), 42
U.S.C. 300gg-26(a), 29 U.S.C. 1185a(a), and 26 U.S.C. 9812.
H.  The Commissioner shall issue guidance and standardized
reporting templates to ensure compliance with the provisions of this
section.  Guidance shall include examples of non-quantitative
treatment limitations as identified by the Centers for Medicare and
Medicaid Services, the Department of Labor, and the Employee
Benefits Security Administration.

I.  No later than December 31, 2021, and by December 31 of each
year thereafter, the Commissioner shall make available to the public
the reports submitted by insurers, as required in subsection E of
this section, during the most recent annual cycle.
1.  The Commissioner shall identify insurers that have failed in
whole or in part to comply with the full extent of reporting
required in this section and shall make a reasonable attempt to
obtain missing reports or information by June 1 of the following
year.
2.  The reports submitted by insurers and the identification by
the Commissioner of noncompliant insurers shall be made available to
the public by posting on the Internet website of the Insurance
Department.  Any information that is confidential or a trade secret
shall be redacted prior to the public posting.
J.  The Commissioner may promulgate rules pursuant to the
provisions of this section and any provisions of the Paul Wellstone
and Pete Domenici Mental Health Parity and Addiction Equity Act of
2008, as amended, that relate to the business of insurance.
Added by Laws 1999, c. 153, § 2, eff. Jan. 1, 2000.  Amended by Laws
2010, c. 222, § 42, eff. Nov. 1, 2010; Laws 2020, c. 75, § 2, eff.
Nov. 1, 2020; Laws 2021, c. 478, § 28, emerg. eff. May 12, 2021;

‹ Prev All Oklahoma sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.